Salcrozine gastro-resistant tablets contain 500 mg of the active substance mesalazine (also known as 5-aminosalicylic acid), which belongs to a group of drugs called intestinal anti-inflammatory drugs. Salcrozine is indicated in the treatment of ulcerative colitis, an inflammatory bowel disease. Side Effects: Common Side Effects: Nausea, stomach cramps, and headaches. Serious Side Effects: Potential kidney or liver issues. Monitoring by a healthcare provider is important during long-term treatment. Precautions: Allergic Reactions: People allergic to mesalazine or sulfasalazine should avoid this medication. Kidney Issues: Use with caution for individuals with pre-existing kidney conditions. Pregnancy and Breastfeeding: Always consult a healthcare provider before using during pregnancy or breastfeeding.

Uses: Ulcerative Colitis: Used to reduce inflammation in the colon and rectum in people with ulcerative colitis. Crohn’s Disease: Helps manage flare-ups of inflammation in the intestines for patients with Crohn's disease. Benefits: Anti-inflammatory Action: Mesalazine works directly in the intestines to reduce inflammation, which helps alleviate symptoms such as diarrhea, abdominal pain, and bleeding. Targeted Release: The gastro-resistant formulation ensures that mesalazine is released in the intestines, rather than being broken down in the stomach, providing more effective treatment where it’s needed.

The usual dose for Salcrozine 500 mg tablets is 1-2 tablets taken 1-2 times daily, depending on your healthcare provider’s recommendation. Always follow the prescribed dosage for your specific condition.